DFTX NASDAQ
Definium Therapeutics, Inc.
1W: +6.1%
1M: -1.9%
3M: +32.2%
YTD: +66.1%
$22.50
-0.15 (-0.66%)
Weekly Expected Move ±7.8%
$18
$19
$21
$23
$24
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-77M
Net Income
+0.0% YoY
$-43M
Free Cash Flow
+0.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-23.2%
ROA-17.5%
ROIC59.0%
Valuation
P/E-10.3
P/B8.8
EV/EBITDA-27.8
Leverage
Debt/Equity0.00
Current Ratio6.29
Interest Cov.-47.6x
Quality Scores
Piotroski F2/9
Altman Z10.11
Beneish M0.00